Jun 19, 2014
San Francisco-Based Established To Bring Innovative Therapies To Sub-Saharan Africa
Serenus Biotherapeutics, Inc. Established To Bring Innovative Therapies To Sub-Saharan Africa Serenus Biotherapeutics, Inc., a specialty biopharmaceutical company bridging the divide between the world's leading pharmaceutical markets and the growing demand for access to innovative therapies in the emerging nations of Sub-Saharan Africa, announced ... (more)
Inversion Transactions Likely to Continue and Expand into Other Markets and Industries
During recent months there has been a surge in cross-border M&A activity in which U.S. and non-U.S. companies combine in so-called inversion transactions.
Mylan empty-handed while rivals thrive on new deals
CEO Heather Bresch, who said in February that the company was "poised for a transaction this year," is still empty-handed after a sweetened $6.7 billion bid for Meda AB was rejected this week.